Clinical Trials Directory

Trials / Terminated

TerminatedNCT01849796

Transcranial Stimulation (tDCS) For the Treatment of Neuropathic Facial Pain

Transcranial Stimulation (TDCS) For The Treatment of Neuropathic Facial Pain.

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Beth Israel Medical Center · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

A study to determine if transcranial direct current stimulation (tDCS, the device that regulates brain activity, can improve pain in people with neuropathic facial pain and compare which modality (inhibitory tDCS over the somatosensory cortex or excitatory tDCS over the motor cortex) can result in better pain-relief.)

Detailed description

This is a pilot study designed to collect preliminary data on safety and efficacy of transcranial direct current stimulation (tDCS)to relieve pain in subjects with neuropathic facial pain,and to compare two pain-treatment tDCS modalities: inhibitory tDCS stimulation over the somatosensory cortex and excitatory tDCS over the motor cortex.

Conditions

Interventions

TypeNameDescription
DEVICEtDCSTDCS/sham will be delivered using the battery-operated device Phoresor II Auto with two saline-soaked sponge electrodes. To deliver excitatory (anodal) tDCS over the motor cortex, the main electrode will be placed over the motor cortex on the hemisphere contralateral to the major source of pain. The second electrode will be placed on the skin overlying the supraorbital region ipsilateral to the affected area. To deliver inhibitory (cathodal) tDCS, the main electrode will be placed over the somatosensory cortex on the hemisphere contralateral to the major source of pain. The second electrode will be placed on the skin overlying the supraorbital region ipsilateral to the affected area. The current will be delivered at the intensity of 2mA for 20 minutes. To deliver sham, the current will be delivered for 30 sec only to elicit tingling skin sensation but no cortical excitability changes.

Timeline

Start date
2010-10-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2013-05-09
Last updated
2015-12-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01849796. Inclusion in this directory is not an endorsement.